Tabituximab Chimeric Monoclonal Antibody
Tabituximabis a research-grade recombinant antibody targeting CD350. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
FZD10, Fz-10, hFz10, Frizzled-10, CD350, FzE7
UniProt
Q9ULW2
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Chimeric
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
21593156 3x 1.0 µg DNA
GLDC CRISPR All-in-one AAV vector set (with saCas9)(Rat)
Sign In for Pricing
View Details 
JCA51385-01 5000 mg
1-Benzyl-5-methoxy-2-methylindol-3-carbonsureethylester
Sign In for Pricing
View Details JCA51385-02 10000 mg
1-Benzyl-5-methoxy-2-methylindol-3-carbonsureethylester
Sign In for Pricing
View Details 